Myriad Genetics (MYGN) Net Cash Flow Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -260.86% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 73.93% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 722.22% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -115.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -58.16% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -441.96% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 84.25% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | -129.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.09% |
| Dec 31, 2025 | -228.57% |
| Sep 30, 2025 | 1,294.12% |
| Jun 30, 2025 | -1,178.57% |
| Mar 31, 2025 | 68.12% |
| Dec 31, 2024 | -94.93% |
| Sep 30, 2024 | 118.82% |
| Jun 30, 2024 | -102.84% |
| Mar 31, 2024 | -885.71% |
| Dec 31, 2023 | 222.67% |
| Sep 30, 2023 | -642.00% |
| Jun 30, 2023 | 183.28% |
| Mar 31, 2023 | 96.22% |
| Dec 31, 2022 | -23.29% |
| Sep 30, 2022 | -97.18% |
| Jun 30, 2022 | -98.66% |
| Mar 31, 2022 | -393.97% |
| Dec 31, 2021 | 23.64% |
| Sep 30, 2021 | 1,506.35% |
| Jun 30, 2021 | -136.56% |